Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life.

MLA

Christ, Sebastian M., et al. “Validation and Extension of the METSSS Score in a Metastatic Cancer Patient Cohort after Palliative Radiotherapy within the Last Phase of Life.” Clinical and Translational Radiation Oncology, vol. 34, Apr. 2022, pp. 107–11. EBSCOhost, https://doi.org/10.1016/j.ctro.2022.04.005.

APA

Christ, S. M., Schettle, M., Willmann, J., Ahmadsei, M., Seiler, A., Blum, D., Guckenberger, M., Andratschke, N., & Hertler, C. (2022). Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life. Clinical and Translational Radiation Oncology, 34, 107–111. https://doi.org/10.1016/j.ctro.2022.04.005

Chicago

Christ, Sebastian M, Markus Schettle, Jonas Willmann, Maiwand Ahmadsei, Annina Seiler, David Blum, Matthias Guckenberger, Nicolaus Andratschke, and Caroline Hertler. 2022. “Validation and Extension of the METSSS Score in a Metastatic Cancer Patient Cohort after Palliative Radiotherapy within the Last Phase of Life.” Clinical and Translational Radiation Oncology 34 (April): 107–11. doi:10.1016/j.ctro.2022.04.005.